PuSH - Publikationsserver des Helmholtz Zentrums München

Koch, M.* ; Baurecht, H.* ; Ried, J.S. ; Rodriguez, E.* ; Schlesinger, S.* ; Volks, N.* ; Gieger, C. ; Rückert, I.-M. ; Heinrich, L.* ; Willenborg, C.* ; Smith, C.* ; Peters, A. ; Thorand, B. ; Koenig, W.* ; Lamina, C.* ; Jansen, H.* ; Kronenberg, F.* ; Seissler, J.* ; Thiery, J.* ; Rathmann, W.* ; Schunkert, H.* ; Erdmann, J.* ; Barker, J.* ; Nair, R.P.* ; Tsoi, L.C.* ; Elder, J.T.* ; Mrowietz, U.* ; Weichenthal, M.* ; Mucha, S.* ; Schreiber, S.* ; Franke, A.* ; Schmitt, J.* ; Lieb, W.* ; Weidinger, S.*

Psoriasis and cardiometabolic traits: Modest association but distinct genetic architectures.

J. Invest. Dermatol. 135, 1283-1293 (2015)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Psoriasis has been linked to cardiometabolic diseases, but epidemiological findings are inconsistent. We investigated the association between psoriasis and cardiometabolic outcomes in a German cross-sectional study (n=4.185) and a prospective cohort of German Health Insurance beneficiaries (n=1.811.098). A potential genetic overlap was explored using genome-wide data from >22.000 coronary artery disease (CAD) and >4.000 psoriasis cases, and with a dense genotyping study of cardiometabolic risk loci on 927 psoriasis cases and 3.717 controls. Controlling for major confounders, in the cross-sectional analysis psoriasis was significantly associated with type 2 diabetes (T2D, adjusted odd's ratio OR=2.36; 95% confidence interval CI=1.26-4.41) and myocardial infarction (MI, OR=2.26, 95% CI=1.03-4.96). In the longitudinal study, psoriasis slightly increased the risk for incident T2D (adjusted relative risk RR=1.11; 95%CI=1.08-1.14) and MI (RR=1.14; 95%CI=1.06-1.22), with highest risk increments in systemically treated psoriasis, which accounted for 11 and 17 excess cases of T2D and MI per 10,000 person-years. Except for weak signals from within the MHC, there was no evidence for genetic risk loci shared between psoriasis and cardiometabolic traits. Our findings suggest that psoriasis, in particular severe psoriasis, increases risk for T2D and MI, and that the genetic architecture of psoriasis and cardiometabolic traits is largely distinct.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Genome-wide Association; Coronary-artery-disease; Major Histocompatibility Complex; Cardiovascular-disease; Susceptibility Loci; Metabolic Syndrome; Risk-factors; Metaanalysis; Prevalence; Atherosclerosis
ISSN (print) / ISBN 0022-202X
e-ISSN 1523-1747
Zeitschrift Journal of Investigative Dermatology, The
Quellenangaben Band: 135, Heft: 5, Seiten: 1283-1293 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort New York, NY
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Genetic Epidemiology (IGE)
Institute of Epidemiology II (EPI2)
CCG Biomarker for the subclassification of T2DM (KKG-KDB)
CCG Nutrigenomics and Type 2 Diabetes (KKG-KDN)